IL-1-driven stromal–neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapiesMatthias Friedrich, Hannah Sharpe, Matthew Jackson et al.|Nature Medicine|2021Cited by 289
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel diseaseTom Thomas, Christopher D. Buckley, Charlotte Rich‐Griffin et al.|Nature Immunology|2024Cited by 83